|
GNAQ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.113200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.978000E-01 |
| Normal-vs-Stage2 |
2.546000E-01 |
| Normal-vs-Stage3 |
3.443600E-02 |
| Normal-vs-Stage4 |
2.507600E-02 |
| Stage1-vs-Stage2 |
4.046000E-01 |
| Stage1-vs-Stage3 |
3.793500E-02 |
| Stage1-vs-Stage4 |
3.644200E-02 |
| Stage2-vs-Stage3 |
5.227800E-01 |
| Stage2-vs-Stage4 |
3.399600E-01 |
| Stage3-vs-Stage4 |
5.855000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.484570E-01 |
| Normal-vs-AfricanAmerican |
7.787200E-01 |
| Normal-vs-Asian |
5.485800E-01 |
| Caucasian-vs-AfricanAmerican |
1.896010E-01 |
| Caucasian-vs-Asian |
5.463200E-01 |
| AfricanAmerican-vs-Asian |
4.959200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.043700E-02 |
| Normal-vs-Female |
3.140600E-01 |
| Male-vs-Female |
3.140600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.509400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.282000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.184200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.779000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.374300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.397650E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.761400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.684200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.076600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.726000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.822600E-03 |
| Classical-VS-Follicular |
4.106200E-01 |
| Classical-VS-Other |
2.203800E-01 |
| Classical-VS-Normal |
5.558800E-01 |
| Tall-VS-Follicular |
1.042840E-01 |
| Tall-VS-Other |
8.219800E-01 |
| Tall-VS-Normal |
1.405970E-02 |
| Follicular-VS-Other |
3.784400E-01 |
| Follicular-VS-Normal |
2.850400E-01 |
| Other-VS-Normal |
1.108240E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.768150E-01 |
| Normal-vs-N1 |
2.916200E-01 |
| N0-vs-N1 |
9.555000E-01 |
|
|
